๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Thalassemia

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants NCT03937817n/a1 site๐Ÿ“ Bethesda National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia NCT05426252Phase 1, Phase 21 site๐Ÿ“ Toronto The Hospital for Sick Children ยท Tests: Abatacept, Sirolimus ฮ’-Thalassemia Treatment with KL003 Cell Injection NCT06280378Phase 1, Phase 22 sites๐Ÿ“ Shanghai๐Ÿ“ Tianjin Kanglin Biotechnology (Hangzhou) Co., Ltd. ยท Tests: KL003 Cell Injection Drug Product European Rare Blood Disorders Platform (ENROL) NCT06250595n/a1 site๐Ÿ“ Barcelona Hospital Universitari Vall d'Hebron Research Institute ยท Tests: Collection of clinical and laboratory data from EHR. Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent ฮฒ-thalassemia NCT05776173NA1 site๐Ÿ“ Shanghai Shanghai BDgene Co., Ltd. ยท Tests: BD211 Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease NCT02675959Phase 24 sites๐Ÿ“ Los Angeles๐Ÿ“ Gainesville๐Ÿ“ Valhalla New York Medical College ยท Tests: Defibrotide Long-term Follow-up Study of BRL-101 for TDT NCT06298630n/a7 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen Bioray Laboratories ยท Tests: Assessments A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials NCT04064060Phase 3143 sites๐Ÿ“ Los Angeles๐Ÿ“ Oakland๐Ÿ“ Stanford Celgene ยท Tests: Luspatercept A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent ฮฑ-Thalassemia Participants NCT05757245Phase 11 site๐Ÿ“ Nanning First Affiliated Hospital of Guangxi Medical University ยท Tests: GMCN-508A Drug Product Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (ฮฒ)-Thalassemia NCT04143724Phase 226 sites๐Ÿ“ Los Angeles๐Ÿ“ New York๐Ÿ“ Guangzhou Celgene ยท Tests: ACE-536 A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or ฮฒ-thalassemia NCT06073860n/a2 sites๐Ÿ“ Seoul๐Ÿ“ Seoul Bristol-Myers Squibb ยท Tests: Luspatercept Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe ฮฒ-Hemoglobinopathies NCT06647979Phase 11 site๐Ÿ“ Boston Daniel Bauer ยท Tests: autologous bone marrow derived CD34+ HSPCs electroporated with BCL11A enhancer targeting Cas9 ribonucleoprotein, Sequenโ€ฆ A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia NCT06609226Phase 3107 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Los Angeles Novo Nordisk A/S ยท Tests: Etavopivat A, Etavopivat B, Etavopivat C Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children NCT07725263n/a1 site๐Ÿ“ Haikou Haikou Affiliated Hospital of Central South University Xianโ€ฆ ยท Tests: Liposomal Amphotericin B (LAmB) AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion NCT04099966Phase 21 site๐Ÿ“ Valhalla Mitchell Cairo ยท Tests: alpha beta depletion International Registry of Patients With Alpha Thalassemia NCT04872179n/a1 site๐Ÿ“ San Francisco University of California, San Francisco Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent ฮฒ-Thalassemia and Severe Sickle Cell Disease NCT05477563Phase 36 sites๐Ÿ“ New York๐Ÿ“ Charlotte๐Ÿ“ Nashville Vertex Pharmaceuticals Incorporated ยท Tests: CTX001 Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease NCT01245179Phase 11 site๐Ÿ“ Augusta Abdullah Kutlar ยท Tests: panobinostat A Study of Safety and Efficiency of AND017 in Patients With ฮฒ-thalassemia NCT06302491Phase 25 sites๐Ÿ“ Guangzhou๐Ÿ“ Maoming๐Ÿ“ Liuzhou Kind Pharmaceuticals LLC ยท Tests: AND017 capsules, AND017 Placebo MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Fludarabine, Busulfan, Melphalan, Rituximab, Levetiracetam ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders NCT04398628n/a76 sites๐Ÿ“ Phoenix๐Ÿ“ Little Rock๐Ÿ“ Los Angeles American Thrombosis and Hemostasis Network A Study of Participants with ฮ’-Thalassemia Treated with Betibeglogene Autotemcel NCT06271512n/a6 sites๐Ÿ“ Oakland๐Ÿ“ Palo Alto๐Ÿ“ Minneapolis Genetix Biotherapeutics Inc. ยท Tests: No Intervention the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent ฮฒ-Thalassemia NCT05864170EARLY Phase 11 site๐Ÿ“ Shenzhen Shenzhen Hemogen ยท Tests: ฮฒ-globin restored autologous hematopoietic stem cells Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: data collection A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent ฮฒ-thalassemia NCT06772766Phase 12 sites๐Ÿ“ Nanning๐Ÿ“ Haikou Mabwell (Shanghai) Bioscience Co., Ltd. ยท Tests: 9MW3011, 9MW3011 placebo Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia NCT06490627Phase 21 site๐Ÿ“ Karachi National Institute of Blood and Marrow Transplant (NIBMT), โ€ฆ ยท Tests: Thalidomide, Thalidomide the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent ฮฑ-Thalassemia NCT05851105EARLY Phase 11 site๐Ÿ“ Nanning Shenzhen Hemogen ยท Tests: ฮฑ-globin restored autologous hematopoietic stem cells T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias NCT03653338Phase 1, Phase 21 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: CD3/CD19 depleted leukocytes, CD45RA depleted leukocytes, Hydroxyurea, Rituximab, Alemtuzumab Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With ฮฒ-TTD NCT07207577NA1 site๐Ÿ“ Chambรฉry Centre Hospitalier Metropole Savoie ยท Tests: Maximal incremental exercise test
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy